Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus.
J Taibah Univ Med Sci
; 18(1): 9-18, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36398015
Anti-inflammatory; Anti-oxidant; BUN, blood urea nitrogen; DMSO, dimethyl sulfoxide solution; ELISA, enzyme linked immunosorbent assay; FGT, fast glucose test; GSH, glutathione; HDACi, histone deacetylase inhibitor; HOMA-IR, homeostatic model assessment for insulin resistance index; Histone deacetylases inhibitors; IL-1ß, interleukin-1 beta; IP, intraperitoneal; NADPH-oxidase, nicotinamide adenine dinucleotide phosphate hydrogen oxidase enzyme; NODAT, new-onset diabetes after transplantation; New-onset diabetes after transplantation; PO, oral gavage; TNF-α, tumor necrosis factor-α; Tacro, tacrolimus; Tacrolimus; Vorino, vorinostat; Vorinostat
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Taibah Univ Med Sci
Ano de publicação:
2023
Tipo de documento:
Article